Sam Possemiers
CEO
MRM Health
Zwijnaarde, Belgium
23 profile visitsSpeaker
My organisation
MRM Health is a Belgian clinical-stage biotech developing innovative therapeutics for inflammatory, CNS and metabolic diseases. Our most advanced program MH002 is in preparation for pivotal clinical development in Ulcerative Colitis, upon obtaining positive clinical results in a phase 1/2 clinical trial, and is being evaluated in the orphan disease indication Pouchitis. MRM Health leverages on its disruptive CORAL® technology platform to design disease-focused microbiome-based biotherapeutics, based on combinations of 5 to 10 live gut bacteria, and manufacture these in a single standardized and scalable process. In addition to our program in Inflammatory Bowel Diseases, we additionally have ongoing preclinical programs in Parkinson’s Disease and Spondyloarthritis and partnered programs with IFF in Type 2 Diabetes and NAFLD.
Speaker sessions (1)
Tuesday, 23 September 2025
09:50 - 10:30
Fireside chat - Belgium in action: How biopharma and health-tech leaders accelerate R&D excellence
Location:ImpressionnisteTrack:Morning plenary
- Collaboration
- Health innovation
Join a high-level fireside chat between two of Belgium’s leading health and life sciences CEOs,one from Wallonia, the other from Flanders,as they share how their companies are staying ahead in global R&D.